Population-based study of the prevalence of family history of cancer: Implications for cancer screening and prevention

被引:123
作者
Ramsey, Scott D.
Yoon, Paula
Moonesinghe, Ramal
Khoury, Muin J.
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA USA
关键词
D O I
10.1097/01.gim.0000237867.34011.12
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Family history assessment is gaining importance as a potential public health tool to help determine susceptibility to common cancers. Population-based data on the prevalence of having a family history of common cancers are scant. Methods: We queried survey questions from the National Health Interview Survey, an annual nationwide survey of approximately 36,000 households in the United States, to determine the prevalence of persons reporting one or more first-degree relatives with breast, colorectal, lung, prostate, or ovarian cancer. Results: Breast cancer was the most common condition noted for family members (7.74% of respondents), followed by lung cancer (7.10%), colorectal cancer (4.96%), prostate cancer (4.68%), and ovarian cancer (1.79%). A family history of cancer was more commonly reported by older persons, whites, women, and high-income groups. Conclusion: A substantial proportion of persons in the United States report having a close family member with cancer, and thus may be eligible for earlier or more aggressive cancer screening services.
引用
收藏
页码:571 / 575
页数:5
相关论文
共 19 条
[1]  
*ACS, 2006, ACS CANC DET GUID
[2]   The new genetics - The new genetics in clinical practice [J].
Bell, J .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7131) :618-620
[3]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1044
[4]   American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition [J].
Chlebowski, RT ;
Col, N ;
Winer, EP ;
Collyar, DE ;
Cummings, SR ;
Vogel, VG ;
Burstein, HJ ;
Eisen, A ;
Lipkus, I ;
Pfister, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3328-3343
[5]   The challenge of integrating genetic medicine into primary care [J].
Emery, J ;
Hayflick, S .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7293) :1027-1030
[6]   Physician Assessment of Family Cancer History and Referral for Genetic Evaluation in Colorectal Cancer Patients [J].
Grover, Shilpa ;
Stoffel, Elena M. ;
Bussone, Laoti ;
Tschoegl, Elizabeth ;
Syngal, Sapna .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (09) :813-819
[7]  
*NAT COMPR CANC NE, 2006, GUID DET PREV RISK R
[8]  
*NCI, 2006, SCREEN TEST DET CANC
[9]   CLINICAL GENETICS MEETS PRIMARY-CARE [J].
QURESHI, N ;
RAEBURN, JA .
BRITISH MEDICAL JOURNAL, 1993, 307 (6908) :816-817
[10]  
Ries LAG, 2006, SEER CANC STAT REV 1